Page last updated: 2024-12-07
calcium galactogluconate bromide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
bromolactobionic acid: lactobionic acid calcium salt; compound with calcium bromide; RN given refers to Ca salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 93165 |
| MeSH ID | M0069565 |
Synonyms (22)
| Synonym |
|---|
| calcium bromolactobionate |
| 33659-28-8 |
| D07604 |
| nervolta (tn) |
| bromolactobionic acid |
| calcium bromo lactobionate |
| A821892 |
| unii-46egf47s9v |
| calcibronat |
| 46egf47s9v , |
| calcium bis(4-o-(beta-d-galactosyl)d-gluconate) calcium bromide (1:1) |
| einecs 251-616-3 |
| calabron |
| AKOS015896824 |
| calcium bromolactobionate [mi] |
| calcium galactogluconate bromide |
| calcium bromolactobionate [who-dd] |
| dicalcium;(2r,3r,4r,5r)-2,3,5,6-tetrahydroxy-4-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoate;dibromide |
| Q27258928 |
| DTXSID90955277 |
| calcium bromide 4-o-hexopyranosylhexonate (1/1/1) |
| calciumbromolactobionate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.80
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.80) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 4 (80.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 1 (20.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||